Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Niels Behrendt
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Anatomy
Living Beings
Genes & Molecular Sequences
Procedures
Sign-in to see full Profile
Network (preview)
38
Danø, Keld
18
Ploug, Michael
17
Rønne, E
16
Engelholm, Lars
12
Høyer-Hansen, Gunilla
10
Lund, Leif
9
Bugge, Thomas
6
Holmbeck, Kenn
5
List, Karin
4
Nielsen, Boye
4
Kjøller, Lars
3
Rømer, John
3
Yamada, Susan
3
Wagenaar-Miller, Rebecca
3
Gårdsvoll, Henrik
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Niels Behrendt (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Szabova Ludmila; Yamada Susan S; Wimer Helen; Chrysovergis Kaliopi; Ingvarsen Signe; Behrendt Niels; Engelholm Lars H; Holmbeck Kenn
MT1-MMP and type II collagen specify skeletal stem cells and their bone and cartilage progeny.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(11):1905-16.
-
2009: Engelholm Lars H; Ingvarsen Signe; Jürgensen Henrik J; Hillig Thore; Madsen Daniel H; Nielsen Boye S; Behrendt Niels
The collagen receptor uPARAP/Endo180.
Frontiers in bioscience : a journal and virtual library 2009;14():2103-14.
-
2008: Lund Ida K; Jögi Annika; Rønø Birgitte; Rasch Morten G; Lund Leif R; Almholt Kasper; Gårdsvoll Henrik; Behrendt Niels; Rømer John; Høyer-Hansen Gunilla
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
The Journal of biological chemistry 2008;283(47):32506-15.
-
2008: Ingvarsen Signe; Madsen Daniel H; Hillig Thore; Lund Leif R; Holmbeck Kenn; Behrendt Niels; Engelholm Lars H
Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells.
Biological chemistry 2008;389(7):943-53.
-
2008: Hillig Thore; Engelholm Lars H; Ingvarsen Signe; Madsen Daniel H; Gårdsvoll Henrik; Larsen Jørgen K; Ploug Michael; Danø Keld; Kjøller Lars; Behrendt Niels
A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
The Journal of biological chemistry 2008;283(22):15217-23.
-
2007: Madsen Daniel H; Engelholm Lars H; Ingvarsen Signe; Hillig Thore; Wagenaar-Miller Rebecca A; Kjøller Lars; Gårdsvoll Henrik; Høyer-Hansen Gunilla; Holmbeck Kenn; Bugge Thomas H; Behrendt Niels
Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation.
The Journal of biological chemistry 2007;282(37):27037-45.
-
2007: Wagenaar-Miller Rebecca A; Engelholm Lars H; Gavard Julie; Yamada Susan S; Gutkind J Silvio; Behrendt Niels; Bugge Thomas H; Holmbeck Kenn
Complementary roles of intracellular and pericellular collagen degradation pathways in vivo.
Molecular and cellular biology 2007;27(18):6309-22.
-
2007: Sulek Jay; Wagenaar-Miller Rebecca A; Shireman Jessica; Molinolo Alfredo; Madsen Daniel H; Engelholm Lars H; Behrendt Niels; Bugge Thomas H
Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2007;55(4):347-53.
-
2005: Curino Alejandro C; Engelholm Lars H; Yamada Susan S; Holmbeck Kenn; Lund Leif R; Molinolo Alfredo A; Behrendt Niels; Nielsen Boye Schnack; Bugge Thomas H
Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.
The Journal of cell biology 2005;169(6):977-85.
-
2005: Danø Keld; Behrendt Niels; Høyer-Hansen Gunilla; Johnsen Morten; Lund Leif R; Ploug Michael; Rømer John
Plasminogen activation and cancer.
Thrombosis and haemostasis 2005;93(4):676-81.
-
2004: Udby Lene; Sørensen Ole E; Pass Jesper; Johnsen Anders H; Behrendt Niels; Borregaard Niels; Kjeldsen Lars
Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma.
Biochemistry 2004;43(40):12877-86.
-
2004: Behrendt Niels
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.
Biological chemistry 2004;385(2):103-36.
-
2004: Kjøller Lars; Engelholm Lars H; Høyer-Hansen Maria; Danø Keld; Bugge Thomas H; Behrendt Niels
uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV.
Experimental cell research 2004;293(1):106-16.
-
2003: Behrendt Niels; List Karin; Andreasen Peter A; Danø Keld
The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
The Biochemical journal 2003;371(Pt 2):277-87.
-
2003: Engelholm Lars H; List Karin; Netzel-Arnett Sarah; Cukierman Edna; Mitola David J; Aaronson Hannah; Kjøller Lars; Larsen Jørgen K; Yamada Kenneth M; Strickland Dudley K; Holmbeck Kenn; Danø Keld; Birkedal-Hansen Henning; Behrendt Niels; Bugge Thomas H
uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion.
The Journal of cell biology 2003;160(7):1009-15.
-
2002: List Karin; Haudenschild Christian C; Szabo Roman; Chen WanJun; Wahl Sharon M; Swaim William; Engelholm Lars H; Behrendt Niels; Bugge Thomas H
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.
Oncogene 2002;21(23):3765-79.
-
2002: Schnack Nielsen Boye; Rank Fritz; Engelholm Lars H; Holm Arne; Danø Keld; Behrendt Niels
Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells.
International journal of cancer. Journal international du cancer 2002;98(5):656-64.
-
2001: Engelholm L H; Nielsen B S; Netzel-Arnett S; Solberg H; Chen X D; Lopez Garcia J M; Lopez-Otin C; Young M F; Birkedal-Hansen H; Danø K; Lund L R; Behrendt N; Bugge T H
The urokinase plasminogen activator receptor-associated protein/endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis.
Laboratory investigation; a journal of technical methods and pathology 2001;81(10):1403-14.
-
2001: Høyer-Hansen G; Pessara U; Holm A; Pass J; Weidle U; Danø K; Behrendt N
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
The Biochemical journal 2001;358(Pt 3):673-9.
-
2001: Engelholm L H; Behrendt N
Differential binding of urokinase and peptide antagonists to the urokinase receptor: evidence from characterization of the receptor in four primate species.
Biological chemistry 2001;382(3):435-42.
-
2001: Engelholm L H; Nielsen B S; Danø K; Behrendt N
The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system.
Trends in cardiovascular medicine 2001;11(1):7-13.
-
2000: List K; Jensen O N; Bugge T H; Lund L R; Ploug M; Danø K; Behrendt N
Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
Biochemistry 2000;39(3):508-15.
-
2000: Behrendt N; Jensen O N; Engelholm L H; Mørtz E; Mann M; Danø K
A urokinase receptor-associated protein with specific collagen binding properties.
The Journal of biological chemistry 2000;275(3):1993-2002.
-
1999: List K; Høyer-Hansen G; Rønne E; Danø K; Behrendt N
Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology.
Journal of immunological methods 1999;222(1-2):125-33.
-
1997: Høyer-Hansen G; Behrendt N; Ploug M; Danø K; Preissner K T
The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
FEBS letters 1997;420(1):79-85.
-
1997: de Witte H; Pappot H; Brünner N; Grøndahl-Hansen J; Hoyer-Hansen G; Behrendt N; Guldhammer-Skov B; Sweep F; Benraad T; Danø K
ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts.
International journal of cancer. Journal international du cancer 1997;72(3):416-23.
-
1997: Behrendt N; Danø K
Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi)
FEBS letters 1997;402(2-3):293-4.
-
1997: Høyer-Hansen G; Ploug M; Behrendt N; Rønne E; Danø K
Cell-surface acceleration of urokinase-catalyzed receptor cleavage.
European journal of biochemistry / FEBS 1997;243(1-2):21-6.
-
1997: Plesner T; Behrendt N; Ploug M
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Stem cells (Dayton, Ohio) 1997;15(6):398-408.
-
1996: Behrendt N; Danø K
Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
FEBS letters 1996;393(1):31-6.
-
1996: Behrendt N; Ronne E; Dano K
Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.
The Journal of biological chemistry 1996;271(37):22885-94.
-
1995: Behrendt N; Modvig J
The lethal paraphiliac syndrome. Accidental autoerotic deaths in Denmark 1933-1990.
The American journal of forensic medicine and pathology : official publication of the National Association of Medical Examiners 1995;16(3):232-7.
-
1995: Behrendt N; Rønne E; Danø K
The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.
Biological chemistry Hoppe-Seyler 1995;376(5):269-79.
-
1994: Rønne E; Behrendt N; Ploug M; Nielsen H J; Wöllisch E; Weidle U; Danø K; Høyer-Hansen G
Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay.
Journal of immunological methods 1994;167(1-2):91-101.
-
1994: Weidle U H; Wöllisch E; Rønne E; Ploug M; Behrendt N; de Vries T J; Quax P H; Verheijen J H; van Muijen G N; Ruiter D J
Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy.
Annales de biologie clinique 1994;52(11):775-82.
-
1993: Behrendt N; Rønne E; Danø K
A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking.
FEBS letters 1993;336(3):394-6.
-
1993: Behrendt N; Rønne E; Danø K
Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin.
The Journal of biological chemistry 1993;268(8):5985-9.
-
1993: Ellis V; Behrendt N; Danø K
Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis.
Methods in enzymology 1993;223():223-33.
-
1993: Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
Cellular receptor for urokinase-type plasminogen activator: protein structure.
Methods in enzymology 1993;223():207-22.
-
1992: Høyer-Hansen G; Rønne E; Solberg H; Behrendt N; Ploug M; Lund L R; Ellis V; Danø K
Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
The Journal of biological chemistry 1992;267(25):18224-9.
-
1992: Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
European journal of biochemistry / FEBS 1992;205(2):451-8.
-
1991: Rønne E; Behrendt N; Ellis V; Ploug M; Danø K; Høyer-Hansen G
Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.
FEBS letters 1991;288(1-2):233-6.
-
1991: Ellis V; Behrendt N; Danø K
Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.
The Journal of biological chemistry 1991;266(19):12752-8.
-
1991: Ploug M; Behrendt N; Løber D; Danø K
Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator.
Seminars in thrombosis and hemostasis 1991;17(3):183-93.
-
1991: Behrendt N; Ploug M; Patthy L; Houen G; Blasi F; Danø K
The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
The Journal of biological chemistry 1991;266(12):7842-7.
-
1991: Lund L R; Rønne E; Roldan A L; Behrendt N; Rømer J; Blasi F; Danø K
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
The Journal of biological chemistry 1991;266(8):5177-81.
-
1991: Ploug M; Rønne E; Behrendt N; Jensen A L; Blasi F; Danø K
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
The Journal of biological chemistry 1991;266(3):1926-33.
-
1990: Blasi F; Behrendt N; Cubellis M V; Ellis V; Lund L R; Masucci M T; Møller L B; Olson D P; Pedersen N; Ploug M
The urokinase receptor and regulation of cell surface plasminogen activation.
Cell differentiation and development : the official journal of the International Society of Developmental Biologists 1990;32(3):247-53.
-
1990: Barnathan E S; Kuo A; Karikó K; Rosenfeld L; Murray S C; Behrendt N; Rønne E; Weiner D; Henkin J; Cines D B
Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.
Blood 1990;76(9):1795-806.
-
1990: Ellis V; Wun T C; Behrendt N; Rønne E; Danø K
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
The Journal of biological chemistry 1990;265(17):9904-8.
-
1990: Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen L S; Schleuning W D; Blasi F; Appella E; Danø K
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
The Journal of biological chemistry 1990;265(11):6453-60.
-
1990: Hansen S H; Behrendt N; Danø K; Kristensen P
Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
Experimental cell research 1990;187(2):255-62.
-
1990: Roldan A L; Cubellis M V; Masucci M T; Behrendt N; Lund L R; Danø K; Appella E; Blasi F
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
The EMBO journal 1990;9(2):467-74.
-
1989: Stephens R W; Pöllänen J; Tapiovaara H; Leung K C; Sim P S; Salonen E M; Rønne E; Behrendt N; Danø K; Vaheri A
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
The Journal of cell biology 1989;108(5):1987-95.
-
1989: Picone R; Kajtaniak E L; Nielsen L S; Behrendt N; Mastronicola M R; Cubellis M V; Stoppelli M P; Pedersen S; Danø K; Blasi F
Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
The Journal of cell biology 1989;108(2):693-702.
-
1988: Nielsen L S; Kellerman G M; Behrendt N; Picone R; Danø K; Blasi F
A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
The Journal of biological chemistry 1988;263(5):2358-63.
-
1987: Behrendt N; Hansen O C; Ploug M; Barkholt V; Koch C
Localization and functional significance of a polymorphic determinant in the third component of human complement.
Molecular immunology 1987;24(10):1097-103.
Sign-in to see more
